Hanneke Schuitemaker, PhD, is the Head of Viral Vaccine Discovery and Translational Medicine and Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention B.V. She has been in these roles since 2010 and oversees Janssen’s viral vaccine programmes, including investigational vaccine candidates for HIV, respiratory syncytial virus (RSV), Ebola, Zika, influenza and COVID-19. In addition, she is a Professor of Virology at the Amsterdam University Medical Center.
Hanneke is a medical biologist by training. She received her PhD in medicine in 1992 at the University of Amsterdam and worked for more than 20 years on HIV-1 pathogenesis. This was first at Sanquin (1989-2007), the blood supply foundation in the Netherlands, where she was the Chair of the Department of Clinical Viro-Immunology (1998-2007). She then moved to the Amsterdam University Medical Center (2008-2010), where she was the Chair of the Department of Experimental Immunology. From mid-2003 to mid-2004, she worked as a visiting scientist at The Scripps Research Institute in La Jolla, California. She has successfully trained more than 30 PhD students and co-authored more than 340 peer-reviewed scientific articles.